Register | Login
Intellectual Property Today
RFC Express - Document Management System
2013 Top Patent Firms
2013 Top Trademark Firms
Current Issue

Advertising Opportunities

Click Here

Email A Friend Back to Archived News

GeneLink Receives U.S. Patent for Its DNA-Based Skin Health Assessment

Monday, May 14, 2007

Jersey City, NJ -- GeneLink, Inc. (OTCBB:GNLK) announced today that the Unites States Patent Office issued GeneLink a patent for its proprietary method for assessing skin health in humans. U.S. Patent number 7,211,383, entitled "KITS AND METHODS FOR ASSESSING SKIN HEALTH." was granted on May 1, 2007. This is the latest patent to be granted from a family of patent applications filed by GeneLink in the U.S. and abroad.

GeneLink’s Skin Health Assessment is a DNA-based test used to genetically predict an individual’s risk for a variety of age-associated skin conditions including: premature aging due to excessive oxidative stress, collagen breakdown, photo aging and the skin’s ability to tolerate environmental pollutants.

"The granting of this patent further confirms GeneLink's confidence in it’s ongoing research and the commercial potential of its technology," says Monte Taylor, Jr., GeneLink’s CEO. "Just as important, GeneLink is continuing to develop 'genetically guided product solutions' to help consumers reduce or prevent the risks measured by GeneLink’s tests."

Based on the analysis of key genes, GeneLink’s DNA tests provide information that enables the customization of skin-care products, nutritional products, and health maintenance regimens that can be personalized to meet individual consumer’s need.

GeneLink’s mission is to utilize the latest genetic information and applied technologies to provide services that can help improve the quality of life.

GeneLink’s (patented and patent pending) portfolio of genetic assessment also includes: Oxidative Stress; Comprehensive Cardio; Lipid Metabolism; Bone Density, Healthy Aging; and CoQ10 Efficiency tests. GeneLink markets to companies that manufacture or distribute to the $100 Billion plus health care, nutritional supplement and skin-care industries. Through its subsidiary, DERMAGENETICS®, it markets its DNA UltraCustom system of skin-care products.

For more information visit; for more information about, Dermagenetics, visit

Back to Archived News
Looking for...

  © Copyright 2013 Intellectual Property Today
Download Adobe Reader for free